Half Year 2026 Vimian Group AB Earnings Call Transcript
Good morning and welcome to Vimian second quarter earnings call 2026. I'm Alireza Tajbakhsh, Group CEO, and together with me, I have our CFO, CarlâJohan Zetterberg Boudrie, presenting our results for the second quarter.
We at Vimian continue building upon a good start of the year and report the second quarter with strong revenue and earnings growth as well as margin expansion. Our double-digit growth in the quarter is well ahead of the global animal health market, coupled with strong adjusted EBITDA growth.
We have also closed four acquisitions year-to-date and continue to advance our M&A pipeline with active discussions across all four segments. We've also achieved recognition for our ESG achievements with a new AAA rating with MSCI.
Turning to the numbers a bit more in detail, we report 17% revenue growth and reached EUR121.6 million in revenue in the second quarter. Organic growth was 12% with double-digit growth in specialty pharma, medtech and Veterinary services, our three largest segments. 6% contribution
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
